These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32580001)

  • 1. Radiotherapy target volume definition in newly diagnosed high grade glioma using
    Dissaux G; Dissaux B; Kabbaj OE; Gujral DM; Pradier O; Salaün PY; Seizeur R; Bourhis D; Ben Salem D; Querellou S; Schick U
    Radiother Oncol; 2020 Sep; 150():164-171. PubMed ID: 32580001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy Target Volume Definition in Newly Diagnosed High-Grade Glioma Using 18F-FET PET Imaging and Multiparametric MRI: An Inter Observer Agreement Study.
    Dissaux B; Mazouz Fatmi D; Ognard J; Allard B; Keromnes N; Latreche A; Lepeuve A; Schick U; Bourbonne V; Ben Salem D; Dissaux G; Querellou S
    Tomography; 2022 Aug; 8(4):2030-2041. PubMed ID: 36006068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
    Lohmann P; Stavrinou P; Lipke K; Bauer EK; Ceccon G; Werner JM; Neumaier B; Fink GR; Shah NJ; Langen KJ; Galldiks N
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):591-602. PubMed ID: 30327856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hotspot on 18F-FET PET/CT to Predict Aggressive Tumor Areas for Radiotherapy Dose Escalation Guiding in High-Grade Glioma.
    Allard B; Dissaux B; Bourhis D; Dissaux G; Schick U; Salaün PY; Abgral R; Querellou S
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.
    Song S; Cheng Y; Ma J; Wang L; Dong C; Wei Y; Xu G; An Y; Qi Z; Lin Q; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1458-1467. PubMed ID: 31919633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
    Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automated analysis combining [
    Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.
    Göttler J; Lukas M; Kluge A; Kaczmarz S; Gempt J; Ringel F; Mustafa M; Meyer B; Zimmer C; Schwaiger M; Förster S; Preibisch C; Pyka T
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):392-397. PubMed ID: 27913827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of
    Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric Analysis Combining DSC-MR Perfusion and [18F]FET-PET is Superior to a Single Parameter Approach for Differentiation of Progressive Glioma from Radiation Necrosis.
    Panholzer J; Malsiner-Walli G; Grün B; Kalev O; Sonnberger M; Pichler R
    Clin Neuroradiol; 2024 Jun; 34(2):351-360. PubMed ID: 38157019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of
    Debus C; Waltenberger M; Floca R; Afshar-Oromieh A; Bougatf N; Adeberg S; Heiland S; Bendszus M; Wick W; Rieken S; Haberkorn U; Debus J; Knoll M; Abdollahi A
    Sci Rep; 2018 May; 8(1):7201. PubMed ID: 29740097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of
    Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2257-2265. PubMed ID: 28831534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of
    Moller S; Law I; Munck Af Rosenschold P; Costa J; Poulsen HS; Engelholm SA; Engelholm S
    Radiother Oncol; 2016 Oct; 121(1):132-137. PubMed ID: 27622554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Brain Tumour Perfusion Using Early-Phase
    Filss CP; Cramer J; Löher S; Lohmann P; Stoffels G; Stegmayr C; Kocher M; Heinzel A; Galldiks N; Wittsack HJ; Sabel M; Neumaier B; Scheins J; Shah NJ; Meyer PT; Mottaghy FM; Langen KJ
    Mol Imaging Biol; 2024 Feb; 26(1):36-44. PubMed ID: 37848641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.
    Henriksen OM; Larsen VA; Muhic A; Hansen AE; Larsson HBW; Poulsen HS; Law I
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):103-112. PubMed ID: 26363903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
    Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA
    Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between rCBV Delineation Similarity and Overall Survival in a Prospective Cohort of High-Grade Gliomas Patients: The Hidden Value of Multimodal MRI?
    Latreche A; Dissaux G; Querellou S; Mazouz Fatmi D; Lucia F; Bordron A; Vu A; Touati R; Nguyen V; Hamya M; Dissaux B; Bourbonne V
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.